Every bodily function requires a specific amount of energy and CoQ10 is essential for the body to make this energy. It is also one of the best antioxidant supplements (it protects the body from “rusting”).
Does my body make CoQ10?
Yes. Produced in the body and distributed ubiquitously throughout, CoQ10 has been given the scientific name ubiquinone. It is found in the mitochondria (powerhouse) of every cell, but is especially abundant in body cells with highest metabolic activity, such as the heart, liver, kidneys, brain and muscles..
I heard that CoQ10 can help protect against things like cancer, Parkinson’s disease, and heart disease. Is this true? How does it work?
The building of proteins in the body, from muscles to hormones, requires energy. By its role in energy production, CoQ10 helps protect the body from abnormal protein mutations that result in cancers and age related degenerative diseases, such as Parkinson’s disease. Additionally, CoQ10 stabilizes all cell membranes helping to ensure proper function of the cells and the organs and systems of which they consist, such as the heart and the cardiovascular system.
Can CoQ10 help my cholesterol level?
Yes. In the blood, CoQ10 binds with LDL (bad) cholesterol and is transported into the cells where it is needed for cellular maintenance and repair. This binding prevents the LDL from forming plaque in the blood vessels that causes arteriosclerosis, or “hardening of the arteries”.
How good of an antioxidant is CoQ10?
CoQ10 is THE major natural antioxidant found in the body. It is 100 times more concentrated than Vitamins E and C, in the cell. Like PAC-MAN, antioxidants ‘eat-up’ free radicals and super oxides in the body that would otherwise cause disease. By attacking the cells, free radicals and super oxides cause the body to ‘rust’ much like a car.
If my body ‘makes’ CoQ10, why should I take CoQLIFE as a natural health solution?
Unfortunately, large segments of the population are deficient in CoQ10. With age, CoQ10 production in the body lessens. After age 21 production of CoQ10 in the body begins to decrease until at age 65 it is reduced by 50%. But the body’s need for CoQ10 does not decrease. Since cholesterol and CoQ10 are synthesized in the same pathway in the body, many cholesterol lowering drugs also lower the body’s CoQ10, resulting in fatigue, muscle cramps and heart failure.
Many other commonly used drugs also deplete CoQ10 resulting in low energy syndromes. These drugs include some antibiotics, anti-depressants, hormone replacement therapy, antihypertensive drugs, cardiac drugs, and oral diabetic agents.
A poor diet also contributes to a lowering of the CoQ10.
Since CoQ10 is the most abundant antioxidant in the body, smoking and other environmental pollutants, such as sulfur from a paper factory, bind up the available CoQ10, reducing the amount available for energy.
Which comes first, a reduced CoQ10 level or disease?
Theoretically, a drop in CoQ10 will precede disease. However, certain clinical conditions can further deplete CoQ10 levels. Normal blood levels in adults are between 0.75 and 1.2 µg/L (micrograms per Liter of blood). Clinical conditions result when blood levels drop below 0.55 µg/L. These conditions may be improved by supplementing CoQ10.
Yes, when taken as directed in the doses recommended, ReJennaHA is safe. There may be mild side effects of nausea, diarrhea, headache, or skin rash.
I am allergic to shellfish; can I still take ReJennaHA since it has glucosamine in it?
Yes. If you are allergic to shellfish, you are allergic to the meat of the shellfish, not the shell. The glucosamine is derived from the crushed shell, not the meat. There are no documented reports of allergic reaction to glucosamine in shellfish allergic patients.
Can I take ReJennaHA if I am allergic to chicken?
The source of our Collagen II is chicken sternum. Theoretically, individuals who are allergic to chicken or eggs should not use chicken collagen.
How can taking a product derived from chicken sternum and shellfish provide natural joint relief?
By acting as a nutrient stimulus, it causes the body to produce more of its own collagen and HA helping to replace lost cartilage and fluid, therefore allowing for reduced friction and pain in the joint.
I’ve been taking glucosamine and chondroitin for my joints. I’ve had a little relief but not as much as I had hoped for. Why should I try ReJennaHA?
When compared to the results of clinical testing sponsored by the NIH, ReJennaHA’s combination of ingredients has been shown to be significantly more effective in reducing joint pain and promoting joint health than the prescription drug Celebrex, or the nutritional supplements glucosamine and chondroitin, when taken alone.
Can I take ReJennaHA with other nutritional supplements or drugs?
Tylenol or other products containing acetaminophen may actually reduce the effectiveness of ReJennaHA. If you are diabetic and taking anti-diabetic drugs, check with your doctor. However, clinical research suggests that ReJennaHA doesn't adversely affect diabetes treatment. Check with your doctor if you are taking Coumadin.
When should I take ReJennaHA?
For maximum absorption and benefit, take all four soft gel capsules with your first meal of the day. Some people have reported better results when they split the dose and take it twice daily.
When will I notice a difference?
This is variable and appears to depend upon the severity of the joint condition. Some clients report relief in as little as a few hours; others report that it has taken up to six weeks to notice significant improvement. Healing takes time, be patient.
When will I notice a difference?
This is variable and appears to depend upon the severity of the joint condition. Some clients report relief in as little as a few hours; others report that it has taken up to six weeks to notice significant improvement. Healing takes time, be patient.
Are there any health conditions that would keep me from taking ReJennaHA?
Check with your doctor if you have any of the following: diabetes, prostate cancer, asthma, bleeding disorders.
S Mortensen, S Vadhanavikit and K Folkers. Apparent Effectiveness of Coenzyme Q10 (CoQI0) in Treating Patients with Cardiomyopathy and CoQI0 Levels in Blood and Endomyocardial Biopsies. In Biomedical and Clinical Aspects of Coenzyme Q10. Ed. K Folkers and Y Yamamura. Vol 4:391402,1984. Elsevier Scientific Publications, Amsterdam.
P Langsjoen and A Langsjoen. Overviews of the Use of CoQI0 in Cardiovascular Disease. Biofactors 9 (2-4): 273-284, 1999.
W Judy, J Hall, P Toth and K Folkers. Double Blind-Double Crossover Study of Coenzyme QI0 in Heart Failure. In Biomedical and Clinical Aspects of Coenzyme QI0. Ed. K Folkers and Y Yamamura. Vol 5: 315-323,1986. Elsevier Scientific Publications, Amsterdam.
Parkinson Study Group. Effects of Coenzyme QI0 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline. Arch Neurol: 5a:1541-1550, 2002.
Huntington Study Group. A Randomized, Placebo Controlled Trial of Coenzyme QI0 and Remacemide in Huntington's Disease. Neurology 57: 397-404, 2001.
W Judy, K Folkers and J Hall. Improved Long-Term Survival in Coenzyme Q10 Treated Congestive Heart Failure Patients Compared to Conventionally Treated Patients. Ed. K Folkers, G Littarru and Y Yamagami. Vol 6:291-298, 1991. Elsevier Scientific Publications, Amsterdam.
W Judy, W Stogsdill, J Judy, CoQ10 in the Management of Low Energy and Delayed Development in Children with Prader-Willi Syndrome. In The International Coenzyme QI0 Association, Third Conference 34-35, 2002.
C Shults, R Haas, D Passov and M Beal. Coenzyme QI0 Levels Correlate with the Activities of Complex I and II/III in Mitochondria from Parkinsonian and Non-Parkinsonian Subjects. Ann Neurol42: 261-264, 1997.
S Ogasahara, A Engel, D Frens, and D Mack. Muscle Coenzyme Q Deficiency in Familial Mitochondrial Encephalopathy. Proc Natl Acad Sci USA. 86: 2379-2382, 1989.
A Daltner and G. Ernster. Ubiquinol. An Endogenous Lipid-Soluble Antioxidant in Animal Tissues In: Ozben T (ed) Free Radicals, Oxidative Stress and Antioxidants. Pathological and Physiological Significance. Plenum Press, New York, pp 293-314, 1988
P Langsjoen, P Langsjoen, and K Folkers. Long-Term Efficacy and Safety of Coenzyme QI0 Therapy for Idiopathic Dilated Cardiomyopathy. Am J Cardiol65: 521-523, 1990.
Judy WV, Hall JH, Toth PD, Folkers K. A double blind cross over study of coenzyme QI0. Folkers & Yomamura, eds. Elsevier, Amsterdam. Vol 5; 315-323, 1986.
Judy WV, Folkers K, Hall JH, Improved long term survival in coenzyme QI0 treated congestive heart failure patients compared to conventionally treated patients. In Biomedical and Clinical aspects of Coenzyme QI0. Folkers, Littarru, Yamagami, eds. Elsevier, Amsterdam. Vol 6; 291-298, 1991.
Judy WV, Stogsdill WW, Folkers K. Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Clinical Investigator. 1993; 71 (8); 155-161.
Langsjoen PH, Langsjoen PH, Folkers K. Long term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiology; 1990; 65 (7); 521-23.
Littarru GP, Ho L, Folkers K. Deficiency of coenzyme Ql0 in human heart disease. Part I and II. Int J Vitamin Nutrition Res 1972;42 (2); 291 & 42 (3); 413.
Mortensen SA, Leth A, Agner E, Rohde M. Dose related decrease of serum coenzyme Ql0 during treatment with HMG-CoA reductase inhibitors. Molecular Aspects of Medicine 1997;18;137-144.
Judy WV & Folkers K. Coenzyme Ql0 in prevention and treatment of cancers. ACAM (Lecture) 1998 Fort Lauderdale, Florida.
Judy WV & Folkers K. Coenzyme Ql0 in the treatment of prostate cancer. SIBR Research Technical Report. 1997-PCA-02.
ReJennaHA References:
Molecular Biology of The Cell. Fourth Edition, Ed by Alberts et al. Garland Science Publishers.New York, New York, 2003.
Judy WV, Stogsdill WW, Judy JS. Peak absorption characteristics and steady state bioavailability of a product containing hyaluronic acid and chondroitin from BioCell Collagen II (patented hydrolyzed chicken sternum collagen type II compound). SIBR Research Technical Report BCCII;04-2003.
Hydrolyzed Collagen Type II and Use Thereof: USA patent 6,025,327 (2/15/2000). BioCell Technologies, LLC, Newport Beach, California.
Trentham D., et al. Efficacy of Oral Administration of Type II Collagen in Rheumatoid Arthritis.
Science 261 (5129),1727-1730,1993.
McCarty MF. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Medical Hypothesis 50:507-510, 1998.
Moskowitz R. Role of Collagen Hydrolysate in Joint and Bones Diseases. Arthritis & Rheumatism 30 (2) 87-99, 2000.
Copyright 2012: Cyto-Med, Inc. Natural Health Treatments. All rights reserved.
The above statements have not been evaluated by the Food and Drug Administration. The products promoted and information presented here are not intended to diagnose, treat, cure, or prevent any disease or illness.
The information contained on this website should not be considered medical advice.
